Harmony Biosciences Holdings

Harmony Biosciences Secures FDA Orphan Drug Designation for Pitolisant in Prader-Willi Syndrome Treatment

PLYMOUTH MEETING, PA — The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Harmony Biosciences Holdings, Inc.’s (Nasdaq: HRMY) pitolisant for the treatment of Prader-Willi syndrome …

Harmony Biosciences Secures FDA Orphan Drug Designation for Pitolisant in Prader-Willi Syndrome Treatment Read More

The Wistar Institute

Cutting-Edge Study Connects Gut Health to Aging – New Routes for Chronic Illness Management?

PHILADELPHIA, PA — The Wistar Institute’s associate professor, Dr. Mohamed Abdel-Mohsen, and his team, recently made a ground-breaking discovery, published in the Microbiome. They unveiled a link between viral damage …

Cutting-Edge Study Connects Gut Health to Aging – New Routes for Chronic Illness Management? Read More



American Heart Association

American Heart Association Named Organization of the Year at Peer-to-Peer Fundraising Conference

PHILADELPHIA, PA — The American Heart Association, the nonprofit behind America’s largest peer-to-peer fundraising events, has been recognized as the Organization of the Year at the annual Peer-to-Peer Professional Forum …

American Heart Association Named Organization of the Year at Peer-to-Peer Fundraising Conference Read More